MYBPC3 and cardiac hypertrophy: Left ventricular hypertrophy (LVH) in HCM usually develops during adolescence, but particularly myosin binding protein C (MYBPC3) mutations are slower to manifest and mutation carriers often demonstrate onset of hypertrophy later in life [4].